WHO ICTRP trial
Impact of inhaled BGF 160 on complexity and variability of tidal breathing and…
EUCTR2022-003784-15-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2022-003784-15-FR |
|---|---|
| Public title | Impact of inhaled BGF 160 on complexity and variability of tidal breathing and oscillatory mechanics in stable COPD patient. |
| Scientific title | Impact of inhaled BGF 160 on complexity and variability of tidal breathing and oscillatory mechanics in stable COPD patient. - VARI-OSCIL |
| Primary sponsor | CHU DE LILLE |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | France |
| Conditions | Impact of inhaled BGF 160 on complexity and variability of tidal breathing and oscillatory mechanics in stable COPD patient MedDRA version: 21.0 Level: LLT Classification code 10070975 Term: Chronic obstructive bronchopneumopathy System… |
| Interventions | Trade Name: Trixeo Aérosphère Product Name: Trixéo Aerosphere Product Code: BGF 160 Pharmaceutical Form: Suspension and solution for spray |
| Registration date | Jan 31, 2023 |
| Target size | 35 |
| Secondary IDs | 2022_0422 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: